Telesis Bio Inc (TBIO)
0.3213
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
0.315
-0.01
(-1.96%)
After-Hours: 20:00
Telesis Bio Enterprise Value: 25.08M for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 25.08M |
| April 23, 2024 | 25.15M |
| April 22, 2024 | 24.90M |
| April 19, 2024 | 24.71M |
| April 18, 2024 | 25.38M |
| April 17, 2024 | 26.85M |
| April 16, 2024 | 26.47M |
| April 15, 2024 | 26.78M |
| April 12, 2024 | 27.75M |
| April 11, 2024 | 28.54M |
| April 10, 2024 | 28.25M |
| April 09, 2024 | 28.36M |
| April 08, 2024 | 28.38M |
| April 05, 2024 | 28.66M |
| April 04, 2024 | 29.29M |
| April 03, 2024 | 29.77M |
| April 02, 2024 | 28.61M |
| April 01, 2024 | 28.52M |
| March 28, 2024 | 28.66M |
| March 27, 2024 | 28.94M |
| March 26, 2024 | 28.58M |
| March 25, 2024 | 28.94M |
| March 22, 2024 | 28.79M |
| March 21, 2024 | 29.41M |
| March 20, 2024 | 29.03M |
| Date | Value |
|---|---|
| March 19, 2024 | 31.62M |
| March 18, 2024 | 31.65M |
| March 15, 2024 | 31.01M |
| March 14, 2024 | 30.87M |
| March 13, 2024 | 31.74M |
| March 12, 2024 | 31.74M |
| March 11, 2024 | 31.40M |
| March 08, 2024 | 31.92M |
| March 07, 2024 | 30.74M |
| March 06, 2024 | 30.14M |
| March 05, 2024 | 30.98M |
| March 04, 2024 | 29.89M |
| March 01, 2024 | 31.31M |
| February 29, 2024 | 32.20M |
| February 28, 2024 | 32.24M |
| February 27, 2024 | 32.77M |
| February 26, 2024 | 35.25M |
| February 23, 2024 | 38.86M |
| February 22, 2024 | 29.18M |
| February 21, 2024 | 25.99M |
| February 20, 2024 | 24.89M |
| February 16, 2024 | 24.91M |
| February 15, 2024 | 24.89M |
| February 14, 2024 | 25.30M |
| February 13, 2024 | 24.82M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.535M
Minimum
Jun 29 2022
594.56M
Maximum
Jun 22 2021
86.74M
Average
37.57M
Median
Enterprise Value Benchmarks
| Ainos Inc | 10.53M |
| OpGen Inc | 14.54M |
| Zomedica Corp | 37.09M |
| LENSAR Inc | 13.08M |
| Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.69M |
| Revenue (Quarterly) | 6.977M |
| Total Expenses (Quarterly) | 13.07M |
| EPS Diluted (Quarterly) | -0.61 |
| Gross Profit Margin (Quarterly) | 68.07% |
| Profit Margin (Quarterly) | -253.5% |
| Earnings Yield | -507.3% |
| Normalized Earnings Yield | -416.74 |